Nevus: Clinical Trials

85 trials for Nevus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

46 completed, 14 recruiting, 10 unknown, 5 not yet recruiting. 16 Not applicable, 9 Phase 2, 6 Phase 1, 3 Early Phase 1, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable16Completed 9, Not yet recruiting 2, Recruiting 2, Unknown 2, Terminated 1
Phase 29Completed 5, Withdrawn 2, Not yet recruiting 1, Unknown 1
Phase 16Completed 3, Active not recruiting 1, Enrolling by invitation 1, Withdrawn 1
Early Phase 13Completed 2, Not yet recruiting 1
Phase 33Recruiting 3
Phase 41Completed 1

Follow Nevus: new trials by email Literature Review of Nevus trials Research Report on Nevus

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Development of an Aid to Melanoma Detection Using Artificial Intelligence Algorithms Based on Images From the VECTRA 3D System.
Scanner of the whole body using the VECTRA 3D - Naevi
Not applicableNot yet recruitingAssistance Publique Hopitaux De Marseille10002027-01-012026-10-28
Using an Artificial Intelligence (AI) Tool for Melanoma Diagnosis
Clinical decision support tool - Malignant Melanoma of Skin, Other and Unspecified Malignant Neoplasm of Skin
Phase 3RecruitingMemorial Sloan Kettering Cancer Center140002026-10-152026-10-22
A Pilot Study to Examine the Efficacy and Tolerability of Sirolimus on Epidermal Nevi Lesions in Patients 6 Years Old and Above.
sirolimus topical gel 0.2% - Epidermal Nevi
Early Phase 1Not yet recruitingNorthwestern University142026-10-012026-09-10
A Study to Evaluate the Efficacy and Safety of Everolimus in Patients With Teratment-refractory Vascular Anomalies
Everolimus - Vascular Malformations, Arteriovenous Malformations
Phase 2Not yet recruitingYonsei University672026-04-012026-03-17
Early Detection of Skin Tumors Using a Telemedicine Tool in Primary Care
Intervention with telemedicine tool - Skin Cancer Prevention, Melanoma In Situ
Not applicableRecruitingInstitute of Health Information and Statistics of the Czech Republic14402026-02-012026-11-04
Nevus Removal vs. Conservative Treatment in Halo Nevus With Vitiligo: A Randomized Study
Central Nevus Excision, The Standardized Medication Regimen - Vitiligo, Halo Nevus
Not applicableNot yet recruitingXijing Hospital602026-01-202026-01-15
CongenItal Naevus Cohort for Longitudinal Evaluation
Neurodevelopmental assessment, Meeting with the parents, Patient quality of life assessment - Naevi, Neurodevelopmental Disorder
Not applicableRecruitingNantes University Hospital8192025-07-232026-09-24
Optimizing the Timing for Facial Surgical Dressing Removal
sterile gauze dressing - Nevus, Seborrheic Keratosis (SK)
Not applicableCompletedUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology1442025-06-152026-03-03
Impact of Skin Type on Wonud Healing and Scarring Following Facial Skin Surgery
Nevus, Seborrheic Keratosis (SK)
CompletedUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology1732025-06-152026-02-03
Clonal Hematopoiesis Chemotherapy and Radiation Effects Study
Samples - Lung Cancer (Diagnosis), Osteochondroma
RecruitingDana-Farber Cancer Institute50002025-04-042026-06-30
Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi
Single agent, adjuvant anti-PD1 therapy - Melanoma
RecruitingJohn Kirkwood302025-02-202026-01-26
An Observational Study Using The LumAssure Device In Participants Undergoing Assessment Of Skin Conditions.
Skin Cancers - Basal Cell Carcinoma, Skin Cancers - Squamous Cell Carcinoma
Not yet recruitingUniversity of Auckland, New Zealand30002024-12-132024-10-28
Evaluating an Artificial Intelligence Tool to Help Primary Care Doctors Diagnose Skin Conditions.
AI-based medical device for aided diagnosis in dermatological conditions - Skin Lesions, Melanocytic Nevi
CompletedAI Labs Group S.L92024-06-042026-02-24
Using Artificial Intelligence to Help Doctors Identify Different Skin Conditions and Improve Patient Care
AI-based medical device for aided diagnosis in Dermatology - Dermatitis, Melanoma (Skin Cancer)
CompletedAI Labs Group S.L162024-06-012026-02-24
Reflectance Confocal Microscopy and Molecular Correlation in Atypical Melanocytic Lesions
Melanocytic Nevi, Melanoma (Skin Cancer)
RecruitingUniversity of Modena and Reggio Emilia2002023-11-012025-12-11
INTER-PATHOLOGIST READER STUDY
Nevi, Dysplastic
UnknownOrlucent, Inc5002023-06-152024-02-07
12-week Study of NFX-179 Gel in Subjects With Epidermal Nevi
NFX-179 Gel 1.50% - Epidermal Nevi, Nevus Sebaceus
Phase 2WithdrawnAlbert Chiou2023-06-012024-05-28
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
Samples - Cancer Risk, Cancer Predisposition Syndrome
RecruitingDana-Farber Cancer Institute50002023-04-252026-08-17
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
Tebentafusp, Tebentafusp with Pembrolizumab, Investigators Choice - Advanced Melanoma
Phase 3RecruitingImmunocore Ltd5402022-12-192026-02-25
Comparison of 3 in Vivo Microscopic Imaging Techniques for the Diagnosis of Pigmented Tumors
Fluorescence-Advanced videodermatoscopy, Reflectance confocal microscopy, Super-high magnification dermoscopy - Basal Cell Carcinoma, Lentigo Maligna
CompletedCentre Hospitalier Universitaire de Saint Etienne1612022-11-022024-06-24

Showing 20 of 85. Sign in to see all of them.

Narrower conditions

Melanoma (37)  ·  Dysplastic Nevus Syndrome (22)  ·  Nevus, Pigmented (17)  ·  Skin Neoplasms (10)  ·  Carcinoma, Basal Cell (9)  ·  Keratosis, Seborrheic (8)  ·  Cicatrix (6)  ·  Nevus, Sebaceous of Jadassohn (6)  ·  Carcinoma, Squamous Cell (5)  ·  Colorectal Neoplasms, Hereditary Nonpolyposis (4)  ·  Nevus, Epithelioid and Spindle Cell (4)  ·  Peutz-Jeghers Syndrome (4)  ·  Acne Vulgaris (3)  ·  Hemangioma (3)

Broader conditions

Neoplasms by Histologic Type (85)  ·  Nevi and Melanomas (85)  ·  Neoplasms (83)  ·  Skin and Connective Tissue Diseases (53)  ·  Skin Diseases (50)  ·  Neoplasms by Site (49)  ·  Neoplasms, Germ Cell and Embryonal (38)  ·  Neoplasms, Nerve Tissue (38)  ·  Neuroectodermal Tumors (38)  ·  Neuroendocrine Tumors (38)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (30)  ·  Skin Neoplasms (30)  ·  Genetic Diseases, Inborn (22)  ·  Neoplastic Syndromes, Hereditary (22)

Interventions

burosumab (4)  ·  Dermoscopy (3)  ·  Magnetic Resonance Spectroscopy (2)  ·  Nivolumab (2)  ·  Sampling Studies (2)  ·  pembrolizumab (2)  ·  Betulinic Acid (1)  ·  CA-19-9 Antigen (1)  ·  Data Collection (1)  ·  Diagnostic Imaging (1)  ·  Endoscopic Ultrasound-Guided Fine Needle Aspiration (1)  ·  Everolimus (1)  ·  Genome (1)  ·  Lasers (1)  ·  Lasers, Gas (1)

Sponsors

National Cancer Institute (NCI) (4)  ·  Orlucent, Inc (4)  ·  University of California, Irvine (4)  ·  Massachusetts General Hospital (3)  ·  Medical University of Graz (3)  ·  AI Labs Group S.L (2)  ·  Centre Hospitalier Universitaire de Saint Etienne (2)  ·  Dana-Farber Cancer Institute (2)  ·  John Kirkwood (2)  ·  Mahidol University (2)  ·  Memorial Sloan Kettering Cancer Center (2)  ·  Northwestern University (2)  ·  Ruhr University of Bochum (2)  ·  Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (2)  ·  University of California, Davis (2)

Countries

United States (42)  ·  France (6)  ·  China (5)  ·  Italy (5)  ·  Spain (5)  ·  Austria (4)  ·  Germany (4)  ·  United Kingdom (4)  ·  Israel (3)  ·  Switzerland (3)  ·  Canada (2)  ·  Russia (2)  ·  Sweden (2)  ·  Thailand (2)  ·  Australia (1)

Top investigators

Cathy Shachaf, PhD (3)  ·  Antonio Martorell, PhD (2)  ·  John M Kirkwood, MD (2)  ·  Albert S Chiou, MD, MBA (1)  ·  Amy C. Schefler, MD (1)  ·  Amy Paller, MD (1)  ·  Arman Mashayekhi, MD (1)  ·  Ashfaq Marghoob, MD (1)  ·  Avi Dascalu, MD. Ph.D. (1)  ·  Ayse Esra Koku Aksu, MD (1)  ·  Barbara Binder, MD (1)  ·  Bita Esmaeli, MA, MD (1)  ·  Bruce Tromberg, PhD (1)  ·  Carol Shields, MD (1)

Results publications

PMID 17875874, PMID 19833408, PMID 21262599, PMID 21690528, PMID 22032650, PMID 22367216, PMID 22706980, PMID 27505074, PMID 27707590, PMID 27993903, PMID 28982585, PMID 29186245, PMID 29408205, PMID 30538291, PMID 30674442, PMID 31101596, PMID 31197699, PMID 31326397, PMID 31676359, PMID 32657017, PMID 33161160, PMID 33811164, PMID 34149034, PMID 34637495, PMID 34643612, PMID 34660853, PMID 34693508, PMID 35166713, PMID 35899095, PMID 36997799, PMID 37099777, PMID 37787643, PMID 38309755, PMID 41721625, PMID 41775435

NIH funding

P30CA072720 (1), R01CA176828 (1), R01CA293974 (1), U01CA210170 (1)